The FLAM regimen: revisiting time sequential induction therapy for patients with poor-risk acute myeloid leukemia.
Institute of Cancer and Genetics, School of Medicine, Cardiff University, UK knappers@cardiff.ac.uk.
Steven
S
Knapper
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute; D008297:Male